Welcome to our dedicated page for Acme United SEC filings (Ticker: ACU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Acme United Corporation (ACU) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8‑K and, through the SEC’s EDGAR system, other periodic and transactional filings that describe Acme United’s financial condition, operations and material events.
Recent Form 8‑K filings for Acme United report material events such as quarterly financial results and financing arrangements. For example, the company has filed 8‑K reports announcing results of operations and financial condition for quarters ended June 30 and September 30, with press releases attached as exhibits. Another 8‑K describes Amendment No. 11 to the company’s Loan and Security Agreement with HSBC Bank USA, N.A., extending the maturity of a secured revolving credit facility.
Through its SEC filings, Acme United discloses information about its jurisdiction of incorporation, commission file number, and principal office location in Shelton, Connecticut. Filings also identify officers who sign the reports and reference attached exhibits, such as loan amendments and earnings press releases. These documents complement the company’s earnings materials by providing formal regulatory context for reported results and financing activities.
On Stock Titan, investors can use AI‑powered tools to review and interpret Acme United’s SEC filings. Real‑time updates from EDGAR surface new 8‑K, 10‑Q, 10‑K and related forms as they are filed, while AI summaries highlight key points such as changes in credit facilities, reported net sales and income figures, and other material disclosures. Users can also locate information relevant to risk factors discussed in forward‑looking statement sections of press releases that are incorporated by reference into SEC filings.
For research on ACU, this filings page serves as a starting point to examine the company’s official regulatory history, including current reports, periodic reports, and material agreements as disclosed to the SEC.
Acme United Corporation reported modest growth for 2025, with net sales of $196.5 million, up 1% from 2024, and net income of $10.2 million. Gross margin held steady at 39.4%, while operating income rose slightly to $14.7 million as first aid and medical products drove performance.
The company continued shifting toward healthcare, with first aid and medical products reaching about 66% of sales and the Elite First Aid and My Medic businesses expanding its trauma and emergency response portfolio. Bank debt was reduced, leaving $53.1 million available under a $65 million credit facility, supporting acquisitions, dividends, and growth investments.
ACME United Corp director Susan H. Murphy reported a bona fide gift of 1,200 shares of common stock on March 3, 2026. The gift transaction was recorded at $44.08 per share. After this disposition, she directly holds 5,967 common shares of ACME United.
ACME United Corp Chief Financial Officer Paul G. Driscoll reported option awards and related transactions in company stock. On March 2, 2026, he received an employee stock option for 15,000 shares at an exercise price of
On February 27, 2026, Driscoll exercised 15,000 employee stock options at
ACME UNITED CORP director and President/COO Brian S. Olschann reported option and stock transactions. He received a grant of 20,000 employee stock options at $44.77 per share, with 5,000 options vesting annually from March 2, 2027 through March 2, 2030. He also exercised 15,000 options at $24.92 per share into 15,000 shares of common stock and, in a related transaction with the issuer, disposed of 15,000 common shares at $45.88 per share via a net cash settlement that did not involve issuing new shares.
ACME United Corp director and CEO Walter C. Johnsen reported multiple equity compensation transactions. On March 2, 2026, he received a grant of 25,000 employee stock options at an exercise price of
On February 27, 2026, he exercised 30,000 employee stock options at
Acme United Corporation reported modest sales growth but stronger earnings for 2025 and the fourth quarter. Net sales for Q4 2025 rose to
For the full year 2025, net sales edged up to
Acme acquired My Medic in
Acme United Corporation received an updated large-shareholder disclosure from North Star Investment Management Corporation. As of 12/31/2025, North Star reports beneficial ownership of 252,624 shares of Acme United common stock, representing 6.64% of the outstanding class.
North Star has sole voting and dispositive power over 143,800 shares and shared voting and dispositive power over 108,824 shares. North Star certifies the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Acme United.
The Capital Management Corporation filed an amended Schedule 13G reporting its beneficial ownership of Acme United Corporation common stock as of 12/31/2025. The firm reports beneficial ownership of 540,341.30 shares, representing 14.2% of Acme United’s outstanding common stock.
The Capital Management Corporation has sole voting power over 534,966.30 shares and sole dispositive power over 540,341.30 shares, with no shared voting or dispositive power. The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Acme United.
Acme United Corporation completed an asset acquisition from SLED Distribution, LLC d/b/a "My Medic" and Rapid Medical, LLC, buying substantially all assets of their emergency and first aid products business. The maximum purchase price for the acquired assets is $18,700,000, including $14.6 million paid in cash at closing.
An additional $1,000,000 is contingent on achieving specified revenue milestones during the twelve months ended December 31, 2027, and $3.1 million is subject to a holdback primarily to cover potential indemnification claims. Acme acquired inventory, receivables, equipment, intellectual property, customer and supplier relationships, and certain contracts, while excluding cash, certain contracts, and other non-core items, and only assumed limited specified liabilities. The agreement includes customary representations, warranties, covenants, and indemnification provisions and is governed by Utah law.
Acme United (ACU) reported steady Q3 2025 results. Net sales were $49,063,000, up 2% year over year, with diluted EPS of $0.46 (basic $0.50). Gross margin improved to 39.1% from 38.5%, while SG&A rose to 33.0% of sales. Operating income was $3,007,000, slightly above last year. Net income was $1,903,000 versus $2,226,000 a year ago.
The U.S. segment grew modestly on first aid and medical products, Canada increased 5% (strength in first aid), and Europe rose 13% on e‑commerce school and office products. For the nine months, sales were $149,018,000 and diluted EPS held at $2.03.
Liquidity remained solid: operating cash flow reached $10,079,000 year to date, working capital increased to $76,619,000, and the current ratio improved to 4.47. The company extended its $65 million SOFR+1.75% revolving credit facility to May 31, 2027 and purchased a Mt. Pleasant, TN manufacturing and distribution center for approximately $6.0 million. Management disclosed a previously identified material weakness in IT general controls remains, with remediation expected by December 31, 2025.